Limited observational data are available on the use of nonvitamin K antagonist oral anticoagulants (NOACs) for the treatment of acute venous thromboembolism (VTE) in clinical practice.1 Randomized controlled trials in patients with acute deep vein thrombosis (DVT) and pulmonary embolism (PE) have shown noninferior efficacy and fewer bleeding events with NOACs compared with vitamin K antagonists (VKAs).2-6
Related Posts
Order Antibiotics online
June 8, 2024Buying antibiotics online
June 8, 2024How do antibiotics work?
June 8, 2024Flagyl: a beacon of hope in the fight against trichomoniasis
February 17, 2024Metronidazole for bacterial infection
February 1, 2023